RENAISSANCE TECHNOLOGIES LLC

Position in NRXP — NRX Pharmaceuticals, Inc.

CIK 1037389 NEW YORK, NY

Position in NRXP

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$157,874

-$265,103 QoQ

Shares Held

38,600

-69.9% QoQ

Ownership

0.089%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#22

of 47 holders

Holding Since

Mar 2022

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,952,579,858 across 312 Biotechnology names. NRXP ranks #264 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	13,427,993	$730,617,099
2	CORT	Corcept Therapeutics Inc	5,261,628	$457,498,554
3	INCY	Incyte Corp	3,512,132	$398,135,283
4	VRTX	Vertex Pharmaceuticals Inc / Ma	320,008	$158,957,573
5	JAZZ	Jazz Pharmaceuticals plc	562,073	$135,442,730
6	RPRX	Royalty Pharma plc	1,935,800	$108,540,306
7	TVTX	Travere Therapeutics, Inc.	1,833,079	$104,137,217
8	GMAB	Genmab A/S	3,517,850	$96,635,339

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$157,874	38,600	-69.9%	Shares	Sole	2026-08-13
2025-09-30	$422,977	128,175	-32.1%	Shares	Sole	2025-11-13
2024-03-31	$89,104	188,780	-5.8%	Shares	Sole	2024-05-13
2023-12-31	$92,220	200,480	+22.4%	Shares	Sole	2024-02-13
2023-09-30	$42,582	163,780	+388.9%	Shares	Sole	2023-11-14
2023-06-30	$16,214	33,500	+32.4%	Shares	Sole	2023-08-11
2023-03-31	$16,672	25,300	+43.8%	Shares	Sole	2023-05-12
2022-12-31	$19,536	17,600	+21.8%	Shares	Sole	2023-02-13
2022-09-30	$10,689	14,445	-56.1%	Shares	Sole	2022-11-14
2022-06-30	$19,740	32,900	-76.3%	Shares	Sole	2022-08-12
2022-03-31	$340,557	139,003	—	Shares	Sole	2022-05-13
No filing history on record for this holder in this stock.